2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis.

Worawit LouthrenooNuntana KasitanonWanruchada KatchamartDuangkamol AiewruengsuratParawee ChevaisrakulPraveena ChiowchanwisawakitPornchai DechanuwongPunchong HanvivadhanakulAjanee MahakkanukrauhSiriporn ManavathongchaiChayawee MuangchanPongthorn NarongroeknawinVeerapong PhumethumBoonjing SiripaitoonAnawat SuesuwanSiraphop SuwannarojParichat Uea-AreewongsaSittichai UkritchonPaijit AsavatanabodeeAjchara KoolvisootRatanavadee NanagaraKitti TotemchokchyakarnKanokrut NuntiroojTasanee Kitumnuaypong

Published in: International journal of rheumatic diseases (2017)

These recommendations will help Thai rheumatologists prescribe bDMARDs and tsDMARD more appropriately when treating RA patients.

Keyphrases

rheumatoid arthritis
end stage renal disease
ejection fraction
newly diagnosed
clinical practice
peritoneal dialysis
prognostic factors
cancer therapy
patient reported outcomes